Results 21 to 30 of about 2,903,093 (261)

Personalized medicine in internal medicine

Clinical Medicine (Russian Journal), 2017
Personalized medicine - a new direction in medicine, which is based on the study of various biomarkers and the use of new methods of molecular analysis (primarily evaluating the activity of isoenzymes of cytochrome P450), allowing individualized approach to the selection of both the drugs and the selection of the dosing regimen for the purpose of ...
V G, Kukes, V F, Marinin, Yu V, Olefir, G V, Ramenskaya, N B, Lazareva, V V, Smirnov, M V, Zhuravleva, A B, Prokofiev, E V, Shih, A S, Zhestovskaia, N A, Rumyantsev, D V, Mandich, O A, Goroshko   +12 more
openaire   +2 more sources

Ethics, evidence and economics in the pursuit of “personalized medicine” [PDF]

, 2014
: Despite enthusiastic advocacy for what personalized medicine might be able to deliver and major investments into the development of this, there remain disappointingly few examples of personalized medicine in routine clinical practice today,
Wendy Lipworth, Kerridge, I, Lipworth, Wendy, Lipworth, W, Ian Kerridge, Lewis, Jan, Kerridge, Ian, Jan Lewis   +7 more
core   +1 more source

Application of Patient-Derived Cancer Organoids to Personalized Medicine

, 2022
Cell models are indispensable for the research and development of cancer therapies. Cancer medications have evolved with the establishment of various cell models.
Furukawa, Toru, Toru Furukawa, Masahiro Shiihara, Shiihara, Masahiro   +3 more
core   +1 more source

Personalized Medicine in Kidney Disease

, 2023
The Special Issue “Personalized Medicine in Kidney Disease” is focused on the importance of customized medicine in nephrology as it represents one of the main characteristics of successful therapeutic results [...
Rossella Siligato, Guido Gembillo, Domenico Santoro   +2 more
core   +1 more source

DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer

Experimental and Molecular Medicine, 2023
Increasing evidence indicates that DNA damage-induced apoptosis suppressor (DDIAS) is an oncogenic protein that is highly expressed in a variety of cancers, including colorectal cancer, lung cancer, breast cancer, and hepatocellular carcinoma (HCC).
Joo-Young Im, Mi-Jung Kang, Bo-Kyung Kim, Misun Won   +3 more
doaj   +1 more source

Transcriptomic Analysis of Gene Networks Regulated by U11 Small Nuclear RNA in Bladder Cancer

Frontiers in Genetics, 2021
Small nuclear RNA is a class of non-coding RNA that widely exist in the nucleus of eukaryotes. Accumulated evidences have shown that small nuclear RNAs are associated with the regulation of gene expression in various tumor types.
Zhenxing Wang, Zhenxing Wang, Zhenxing Wang, Xi Wang, Xi Wang, Yaobang Wang, Yaobang Wang, Shaomei Tang, Chao Feng, Chao Feng, Lixin Pan, Lixin Pan, Qinchen Lu, Qinchen Lu, Yuting Tao, Yuting Tao, Yuanliang Xie, Yuanliang Xie, Yuanliang Xie, Qiuyan Wang, Qiuyan Wang, Zhong Tang, Zhong Tang, Zhong Tang   +23 more
doaj   +1 more source

The Case for Personalized Medicine [PDF]

Journal of Diabetes Science and Technology, 2009
Personalized medicine may be considered an extension of traditional approaches to understanding and treating disease, but with greater precision. Physicians may now use a patient's genetic variation or expression profile as well as protein and metabolic markers to guide the selection of certain drugs or treatments.
Edward, Abrahams, Mike, Silver
openaire   +2 more sources

The Promise of Nanotechnology in Personalized Medicine

, 2022
Both personalized medicine and nanomedicine are new to medical practice. Nanomedicine is an application of the advances of nanotechnology in medicine and is being integrated into diagnostic and therapeutic tools to manage an array of medical conditions ...
Khaled Greish, Alghamdi, Maha Ali, Greish, Khaled, Maha Ali Alghamdi, Kesharwani, Prashant, Nicola Virzì, Fallica, Antonino N., Virzì, Nicola, Antonino N. Fallica, Prashant Kesharwani, Valeria Pittalà, Pittalà, Valeria   +11 more
core   +1 more source

Pharmacogenetics and personalized medicine

Saúde & Tecnologia, 2016
Pharmacogenetics aims to identify genetic differences between individuals that may influence the response to drug therapy, improving their effectiveness and safety. Associated with the pharmacogenetics emerges ‘personalized medicine’.
Miguel Brito
doaj   +1 more source

Synaptotagmin 11 scaffolds MKK7–JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis

Journal of Experimental & Clinical Cancer Research, 2022
Background Identifying biomarkers related to the diagnosis and treatment of gastric cancer (GC) has not made significant progress due to the heterogeneity of tumors.
Bo-Kyung Kim, Da-Mi Kim, Hyunkyung Park, Seon-Kyu Kim, Mi-Aie Hwang, Jungwoon Lee, Mi-Jung Kang, Jae-Eun Byun, Joo-Young Im, Minho Kang, Kyung Chan Park, Young Il Yeom, Seon-Young Kim, Haiyoung Jung, Dae-Hyuk Kweon, Jae-Ho Cheong, Misun Won   +16 more
doaj   +1 more source